{"transactions":[{"id":2939764,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-12-17T16:06:44.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of TLANDO."}],"balance_after":7500,"derivative":{"exercise_price":0,"exercise_date":"2020-12-16","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001638599-20-000978","document":"doc4_6961.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859920000978/doc4_6961.xml","form_type":"4"}},{"id":2939763,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T16:06:44.000Z","date":"2020-12-16","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units."}],"balance_after":12750,"source":{"system":"sec-edgar","filing":"0001638599-20-000978","document":"doc4_6961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859920000978/doc4_6961.xml","form_type":"4"}},{"id":3099660,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-25T20:22:59.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant shall vest over a period of three years from the grant date, with one-third vesting on  the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a  24 month period beginning on the first anniversary of the grant date."}],"balance_after":50000,"derivative":{"exercise_price":1.28,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-20-076872","document":"m2023456d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920076872/m2023456d4_4.xml","form_type":"4"}},{"id":3114482,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-10T16:11:33.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":22000,"price":0.9629,"value":21183.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":22000,"derivative":{"exercise_price":0.9629,"exercise_date":"2021-06-10","expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001638599-20-000593","document":"doc4_6751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859920000593/doc4_6751.xml","form_type":"4"}},{"id":3118436,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T20:12:14.000Z","date":"2020-06-04","kind":"purchase","acquired":true,"shares":18000,"price":1.0799,"value":19438.2,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001104659-20-070843","document":"tm2022064d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920070843/tm2022064d4_4.xml","form_type":"4"}},{"id":3489378,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-06-14T20:32:12.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest on the one year anniversary of the date of grant."}],"balance_after":6500,"derivative":{"exercise_price":2.15,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001144204-19-031007","document":"tv523608_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420419031007/tv523608_4.xml","form_type":"4"}},{"id":3489363,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-14T11:10:58.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":10000,"price":1.68,"value":16800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":10000,"derivative":{"exercise_price":1.68,"exercise_date":"2020-06-12","expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001638599-19-000610","document":"doc4_6152.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859919000610/doc4_6152.xml","form_type":"4"}},{"id":3747441,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2018-11-30T23:19:33.000Z","date":"2018-11-29","kind":"sale","acquired":true,"shares":530,"price":0.051,"value":27.03,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":468,"exercise_date":"2014-08-20","expiration_date":"2019-08-20","underlying":"Common Stock","underlying_shares":530},"source":{"system":"sec-edgar","filing":"0001144204-18-062709","document":"tv508276_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420418062709/tv508276_4.xml","form_type":"4"}},{"id":3747440,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Warrants","published_at":"2018-11-30T23:19:33.000Z","date":"2018-11-29","kind":"sale","acquired":true,"shares":9390,"price":0.0977,"value":917.403,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":30.4,"exercise_date":"2016-04-20","expiration_date":"2021-04-20","underlying":"Common Stock","underlying_shares":9390},"source":{"system":"sec-edgar","filing":"0001144204-18-062709","document":"tv508276_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420418062709/tv508276_4.xml","form_type":"4"}},{"id":3747439,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-30T23:19:33.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":53,"price":2.21,"value":117.13,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-062709","document":"tv508276_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420418062709/tv508276_4.xml","form_type":"4"}},{"id":3747438,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-30T23:19:33.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":939,"price":2.2101,"value":2075.2839,"ownership":{"direct":true},"balance_after":53,"source":{"system":"sec-edgar","filing":"0001144204-18-062709","document":"tv508276_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420418062709/tv508276_4.xml","form_type":"4"}},{"id":3790567,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-10-15T23:50:18.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant was divided into a definitive grant of 6,150 shares, which vest in equal monthly installments over a seven month period from the grant date, and a contingent grant of 6,850 shares, which are subject to the following conditions: (i) approval by Cellectar's stockholders of an increase in shares available under the Amended and Restated 2015 Stock Incentive Plan at the Corporation's 2019 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the contingent grant shall vest immediately upon such stockholder approval."}],"balance_after":13000,"derivative":{"exercise_price":2.61,"expiration_date":"2028-10-12","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001144204-18-053880","document":"tv504845_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420418053880/tv504845_form4.xml","form_type":"4"}},{"id":3823830,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-07T01:41:02.000Z","date":"2018-09-06","kind":"disposition_to_issuer","acquired":false,"shares":190,"price":10.07,"value":1913.3,"ownership":{"direct":true},"balance_after":1190,"source":{"system":"sec-edgar","filing":"0001209191-18-049987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118049987/doc4.xml","form_type":"4"}},{"id":3881269,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-28T12:28:20.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":20000,"price":1.33,"value":26600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vesting one year from date of grant"}],"balance_after":20000,"derivative":{"exercise_price":1.33,"exercise_date":"2019-06-27","expiration_date":"2028-06-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001638599-18-000697","document":"doc4_5499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859918000697/doc4_5499.xml","form_type":"4"}},{"id":3892770,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T21:52:47.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing 06/13/2018."}],"balance_after":5000,"derivative":{"exercise_price":24.94,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-038135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118038135/doc4.xml","form_type":"4"}},{"id":4040964,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Redeemable Convertible Note","published_at":"2018-02-22T21:33:07.000Z","date":"2018-02-20","kind":"other","acquired":false,"shares":21600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1:15 reverse stock split effected on February 10, 2017."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects a redeemable convertible note of the Issuer (the \"Note\") that matured, with the face value of the Note repaid to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the option of the Reporting Person, at any time on or before February 19, 2018, the Note was redeemable into cash at a rate of $1 for each $1 principal amount of the Note or convertible into shares of common stock of the Issuer at a conversion rate of $137.85 per share, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Note matured on February 19, 2018."}],"balance_after":0,"derivative":{"exercise_price":137.85,"underlying":"Common Stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0001209191-18-012438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118012438/doc4.xml","form_type":"4"}},{"id":4040963,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Redeemable Convertible Note","published_at":"2018-02-22T21:33:07.000Z","date":"2018-02-20","kind":"other","acquired":false,"price":0,"reported_value":189000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1:15 reverse stock split effected on February 10, 2017."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects a redeemable convertible note of the Issuer (the \"Note\") that matured, with the face value of the Note repaid to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the option of the Reporting Person, at any time on or before February 19, 2018, the Note was redeemable into cash at a rate of $1 for each $1 principal amount of the Note or convertible into shares of common stock of the Issuer at a conversion rate of $137.85 per share, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Note matured on February 19, 2018."}],"derivative":{"exercise_price":137.85,"underlying":"Common Stock","underlying_shares":1371},"source":{"system":"sec-edgar","filing":"0001209191-18-012438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118012438/doc4.xml","form_type":"4"}},{"id":4116973,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-01-02T18:15:40.000Z","date":"2017-12-29","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":7500,"derivative":{"exercise_price":0,"exercise_date":"2017-12-29","expiration_date":"2027-01-25","underlying":"Common stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001638599-18-000027","document":"doc4_5173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859918000027/doc4_5173.xml","form_type":"4"}},{"id":4116972,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-01-02T18:15:40.000Z","date":"2017-12-29","kind":"sale","acquired":false,"shares":1250,"price":3.4732,"value":4341.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $3.43-$3.54."}],"balance_after":5250,"source":{"system":"sec-edgar","filing":"0001638599-18-000027","document":"doc4_5173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859918000027/doc4_5173.xml","form_type":"4"}},{"id":4116971,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-02T18:15:40.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."}],"balance_after":6500,"source":{"system":"sec-edgar","filing":"0001638599-18-000027","document":"doc4_5173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859918000027/doc4_5173.xml","form_type":"4"}},{"id":4257238,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-14T20:52:43.000Z","date":"2017-07-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 15, 2017."}],"balance_after":10000,"derivative":{"exercise_price":4.4,"exercise_date":"2018-06-15","expiration_date":"2027-07-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-045213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919117045213/doc4.xml","form_type":"4"}},{"id":4297889,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-06-01T22:04:45.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal annual increments over a period of three years from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":1.74,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-17-030683","document":"v468272_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420417030683/v468272_4.xml","form_type":"4"}},{"id":4477116,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":144566,"kind":"person","name":"HILL STEPHEN A","position":1,"cik":"0001237404","reported_name":"HILL STEPHEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-01-30T21:40:43.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 31, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":10000,"derivative":{"exercise_price":0,"exercise_date":"2017-12-31","expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001638599-17-000128","document":"doc4_4499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237404/000163859917000128/doc4_4499.xml","form_type":"4"}}]}